Life Science Instrumentation Market Size, Share & Industry Analysis, By Product Type (Spectroscopy Instruments, Chromatography Instruments, PCR & Nucleic Acid Amplification Systems, and Imaging & Microscopy Instruments [Optical, Fluorescence, and Confocal Microscopes]), By Mobility (Benchtop, Floor-standing/Standalone, and Portable & Handheld), By Application (Clinical & Diagnostic Applications and Research Applications), By End User (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2026-2034

The global life science instrumentation market size was valued at USD 62.50 billion in 2025. The market is projected to grow from USD 65.92 billion in 2026 to USD 105.33 billion by 2034, exhibiting a CAGR of 6.0% during the forecast period.

Life science instrumentation refers to the medical devices and automated systems that are used to observe, measure, and analyze biological samples. The increasing diagnostic procedure volumes, increasing pharmaceutical and biotechnology research investments, and the development of healthcare infrastructure are resulting in a growing adoption rate for these systems in the market. The growing expansion of biopharmaceutical manufacturing and quality-control testing is further boosting the demand for these devices in the market.

• For instance, according to the 2025 data published by the Centers for Medicare & Medicaid Services (CMS), the healthcare expenditure is USD 5.3 trillion in the U.S.

The increasing incorporation of technological advancements in these devices by major players, such as Thermo Fisher Scientific Inc. and Agilent Technologies, Inc., is further contributing to market expansion.

Life Science Instrumentation Market Trends

Increasing Laboratory Automation and Robotics Adoption to Improve Throughput and Reproducibility is a Key Market Trend

There is an increasing adoption of automated liquid-handling platforms, robotic workstations, sample-management systems, automated imaging instruments, and integrated laboratory software across biotechnology, pharmaceutical, academic, and clinical research settings. The shift is mainly due to rising sample volumes, increasingly complex experimental protocols, limited availability of skilled laboratory personnel, and growing demand to generate consistent and traceable results.

Automation allows laboratories to standardize repetitive activities, including plate handling, pipetting, PCR preparation, nucleic-acid extraction, high-throughput screening, cell-based assays, and LC-MS sample preparation, which further minimizes operator-dependent variability, reduces contamination and transcription errors, and enables instruments to operate for longer periods with limited human intervention, further boosting the adoption rate of these systems in the market.

• For instance, in December 2025, Beckman Coulter, Inc., launched the Biomek i3 Benchtop Liquid Handler with an aim to strengthen its product portfolio.

Market Dynamics

Market Drivers

Download Free sample to learn more about this report.

Increasing Pharmaceutical and Biotechnology R&D Expenditure to Fuel Market Growth

The rising research and development expenditure across pharmaceutical & biotechnological companies, universities, and public research institutions is a major driver of the market. The drug discovery and development process heavily depends on advanced laboratory technologies for compound screening, target identification, molecular characterization, toxicity assessment, clinical research, process development, and quality control. The increasing R&D spending is supporting the procurement and utilization of these advanced systems, including mass spectrometers, chromatography systems, PCR instruments, and others.

• For instance, according to 2024 statistics published by the Centers for Disease Control & Prevention (CDC), about 1 in 20 adults has coronary artery disease in the U.S.

This, coupled with growing technological advancements in these systems and improving healthcare access, is further contributing to the adoption rate of these devices in the market. Increasing key companies’ focus on introducing R&D initiatives to launch innovative products is anticipated to boost the global life science instrumentation market growth in the coming years.

Market Restraints

High Cost Associated with Advanced Life Science Instruments to Hinder Market Growth

There is a growing demand for innovative life science instruments, including mass spectrometers, next-generation sequencing platforms, and others in healthcare organizations and institutions. However, one of the key factors that hinders the adoption of these instruments is the high cost associated with these devices. The capital cost associated with the purchase and implementation of life instrumentation devices is very high, owing to the addition of manufacturing costs, distributors’ margins, and service costs.

Additional costs associated with installation, temperature and vibration control, facility renovations, calibration, specialized gases, preventive maintenance, service contracts, software licences, data storage, validation, consumables, and trained technical professionals significantly increase the overall cost of ownership. These expenses make it challenging for small and mid-sized pharmaceutical companies and healthcare facilities to adopt these instruments, thereby hampering market growth, especially in the developing markets.

• For instance, according to a 2022 article published by Duke University, the purchase and installation of a cryo-electron microscope, including required renovation costs, costs about USD 8.0 million – 10.0 million.

Market Opportunities

Expansion of Life Science and Biopharmaceutical Infrastructure to Create an Opportunity

The ongoing expansion of life science research, pharmaceutical manufacturing, biotechnology incubation, and bioprocessing infrastructure across developing countries is anticipated to create substantial opportunities for the global market. Countries, including Brazil, India, China, and several other economies, are focusing on investments in domestic vaccine production, genomic research, biosimilars, biologics, diagnostic capabilities, and biotechnology start-up companies.

Additionally, the rapid establishment of new research laboratories, manufacturing plants, bio-incubators, quality-control facilities, and other start-ups is augmenting the demand for advanced mass spectrometers, sequencing platforms, PCR instruments, flow cytometers, and other instruments, thereby creating a lucrative opportunity for the manufacturers in the market.

• According to 2026 data published by Omnicuris Healthcare Pvt Ltd., there are about 11,800 biotechnology start-ups in India.

Market Challenges

Limited Healthcare Access in Emerging Countries to Hamper Market Growth

There is an increasing demand for novel life science instruments, including mass spectrometers and PCR instruments, among others. However, the integration complexities with digital laboratory systems, limited pharmaceutical and biotechnological spending, stringent regulatory compliance, shortage of skilled laboratory professionals, along with inadequate reimbursement policies, especially in developing nations, are resulting in limited access to healthcare settings.

A limited number of pharmaceutical and biotechnological companies and healthcare facilities are hampering the adoption rate of these devices, especially in developing countries, including Mexico, Brazil, and others.

• For instance, according to 2023 statistics published by The World Bank Group (WBG), approximately 4.5 billion people lack full access to essential health services globally.

SEGMENTATION ANALYSIS

By Product Type

Increasing Number of Product Launches Led to Spectroscopy Instruments Segmental Dominance

Based on the product type, the market is classified into spectroscopy instruments, chromatography instruments, PCR and nucleic acid amplification systems, imaging and microscopy instruments, laboratory automation and sample preparation instruments, and others. Spectroscopy instruments are divided into mass spectrometers, atomic spectrometers, and others. Chromatography instruments are classified into liquid chromatography systems, gas chromatography systems, and others. PCR and nucleic acid amplification systems are divided into real-time PCR systems, digital PCR systems, and others. Imaging and microscopy instruments are classified into optical microscopes, fluorescence microscopes, confocal microscopes, and others. Laboratory automation and sample preparation instruments are divided into automated liquid handling systems, automated sample preparation systems, and others.

The spectroscopy instruments segment held the largest life science instrumentation market share in 2025 due to the growing research and development activities across pharmaceutical and biotechnological companies. This, along with the rising emphasis of key companies on launching novel instruments, is further anticipated to contribute to the segment growth.

• For instance, in June 2025, Thermo Fisher Scientific Inc. launched two new mass spectrometers, the Orbitrap Astral Zoom and Orbitrap Excedion Pro, designed to enhance research capabilities in proteomics, biopharmaceutical development, and complex disease biology.

The chromatography instruments segment is expected to grow at a CAGR of 5.2% over the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Mobility

Benchtop Segment Led Market Due to Its Easy Installation

Based on mobility, the market is segmented into benchtop, floor-standing/standalone, and portable & handheld.

The benchtop segment dominated the global market with a share of 66.7% in 2025. The segment growth is driven by the benefits associated with benchtop instruments, including compact footprint, lower acquisition cost, easier installation, and others. This, along with a growing number of key companies focusing on the introduction of benchtop life science instruments, is further expected to contribute to the segmental growth.

• For instance, in April 2026, Thermo Fisher Scientific Inc. announced the Applied Biosystems PowerFlex Thermal Cycler, a next-generation polymerase chain reaction (PCR) instrument designed to help deliver enhanced flexibility, precise thermal performance, and improved productivity for modern molecular biology laboratories.

The portable & handheld segment is set to flourish with a growth rate of 7.7% over the forecast period.

By Application

Rising Number of Clinical Studies Boosted Research Applications Segment Growth

Based on application, the market is segmented into clinical & diagnostic applications, research applications, and others.

The research applications segment dominated the global market with a 53.3% share in 2025. The segment growth is supported by the increasing number of clinical studies, resulting in a growing adoption of innovative life science instruments.

• For instance, according to the 2025 data published by the National Center for Biotechnology Information (NCBI), it was reported that about 593,857 clinical studies were registered in the U.S.

The clinical & diagnostic applications segment is set to flourish with a growth rate of 5.8% over the forecast period.

By End User

Increasing Number of Pharmaceutical & Biotechnological Companies Fueled Segment Growth

Based on end user, the market is divided into hospitals & diagnostic laboratories, pharmaceutical & biotechnological companies, academic & research institutes, and others.

The pharmaceutical & biotechnological companies segment dominated the market in 2025. The increasing research and development activities, growing pharmaceutical spending, increasing number of pharmaceutical and biotechnological companies, among others, are some of the key factors contributing to the segment growth. Furthermore, the segment is set to hold a 36.2% share in 2026.

• For instance, according to 2025 data published by Cross River Therapy, there are about 5,000 pharmaceutical companies in the U.S.

Hospitals & diagnostic laboratories are projected to grow at a 5.6% CAGR during the forecast period.

Life Science Instrumentation Market Regional Outlook

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024, valued at USD 24.21 billion, and also took the leading share in 2025 with USD 25.32 billion. The growing advancements in life science instruments, high healthcare spending, and adoption of advanced instruments are some of the factors contributing to market growth in the region.

U.S. Life Science Instrumentation Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 24.97 billion in 2026, accounting for roughly 37.9% of global sales.

Europe

Europe is projected to record a growth rate of 7.7% in the coming years, which is the second highest among all regions, and reach a valuation of USD 15.95 billion in 2026. The growing number of academic institutions and rising drug development activities in major European countries are likely to support the market growth.

U.K. Life Science Instrumentation Market

The U.K. market in 2026 is estimated at around USD 2.77 billion, representing roughly 4.2% of global revenues.

Germany Life Science Instrumentation Market

Germany market size is projected to reach approximately USD 3.51 billion in 2026, equivalent to around 5.3% of global sales.

Asia Pacific

The Asia Pacific market size is estimated to reach USD 17.24 billion in 2026 and secure the position of the third-largest region. The growing demand for precision medicine and increasing number of clinical studies are further likely to support the market expansion.

Japan Life Science Instrumentation Market

The Japan market in 2026 is estimated at around USD 3.13 billion, accounting for roughly 4.7% of global revenues. Japan has historically reported relatively increasing pharmaceutical expenditure, with a growing demand for personalized medicine among the patient population.

China Life Science Instrumentation Market

China’s market is projected to be one of the largest globally, with 2026 revenues estimated at around USD 8.69 billion, representing roughly 13.2% of global sales.

India Life Science Instrumentation Market

The India market size in 2026 is estimated at around USD 0.82 billion, accounting for roughly 1.2% of global revenues.

Latin America and Middle East & Africa  

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 3.35 billion in 2026 due to increasing demand for precision medicine and advancements in genomics, proteomics, and molecular diagnostics. The Middle East & Africa market is also anticipated to grow at a considerable CAGR due to increasing adoption of automation, artificial intelligence, and high-throughput analytical technologies in the region. In the Middle East & Africa, the GCC is set to reach a valuation of USD 1.86 billion in 2026.

South Africa Life Science Instrumentation Market

The South Africa market is projected to reach around USD 0.16 billion in 2026, representing roughly 0.3% of global revenues.

Competitive Landscape

Key Industry Players

Rising Collaborations among Key Players to Support Their Dominance

Thermo Fisher Scientific Inc. and Agilent Technologies, Inc. are major companies in the market. A significant instrument portfolio, along with a significant focus on strategic initiatives globally, is one of the key factors supporting the dominance of these companies in the market. Furthermore, the rising focus of key companies on acquisitions and collaborations with other companies to increase their brand presence is likely to increase their global market share.

• For instance, in January 2026, Thermo Fisher Scientific Inc. collaborated with NVIDIA to power AI-based solutions and laboratory automation at scale with an aim to strengthen its market presence.

Other key players, including Waters Corporation, Bruker, and Shimadzu Corporation, focus on research and development activities to launch new devices to strengthen their presence in the market.

List of Key Life Science Instrumentation Companies Profiled

• Thermo Fisher Scientific Inc. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Waters Corporation (U.S.)
• Bruker (U.S.)
• Shimadzu Corporation (Japan)
• Beckman Coulter, Inc. (U.S.)
• SCIEX (U.S.)
• Leica Microsystems (Germany)
• Bio-Rad Laboratories, Inc. (U.S.)
• Illumina, Inc. (U.S.)

KEY INDUSTRY DEVELOPMENTS

• June 2026: Waters Corporation introduced the Waters Xevo MRT P10 Mass Spectrometer, a high-resolution Quadrupole Time-of-Flight (QToF) System for high-throughput multiomics, bioanalysis, and biopharmaceutical laboratories.
• April 2026: Bio-Rad Laboratories, Inc., a global company in life science research and clinical diagnostics products, launched the PTC Harmony Thermal Cycler line, designed to offer broader access to optimized workflows for PCR applications such as sequencing, cloning, and genotyping.
• March 2026: Eppendorf, a company that develops, manufactures, and distributes instruments, consumables, and services for use, launched the SpinPro 6 R centrifuge, a new range of SpinPro floor-standing and benchtop centrifuges.
• March 2026: Leica Microsystems, a Danaher company and a provider of microscopy and scientific solutions, launched the Viventis SCAPE light sheet microscope.
• May 2025: Agilent Technologies Inc. launched its latest innovation in liquid chromatography (LC)-mass detection, the Agilent InfinityLab Pro iQ Series, with an aim to strengthen its product channel.

REPORT COVERAGE

The report provides a detailed global life science instrumentation market analysis and focuses on key aspects such as leading companies and market segmentation, including product type, mobility, application, and end user. Besides this, the global report offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market over recent years.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation